The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis.
Elife
; 52016 05 24.
Article
in En
| MEDLINE
| ID: mdl-27215734
Key words
Full text:
1
Collection:
01-internacional
Health context:
3_ND
Database:
MEDLINE
Main subject:
Oxazoles
/
Leishmania donovani
/
Leishmaniasis, Visceral
/
Nitroimidazoles
/
Antiprotozoal Agents
/
Antitubercular Agents
Limits:
Animals
Language:
En
Journal:
Elife
Year:
2016
Document type:
Article